ALFENTANIL PHARMACOKINETICS IN PRETERM INFANTS

被引:39
作者
MARLOW, N
WEINDLING, AM
VANPEER, A
HEYKANTS, J
机构
[1] JANSSEN PHARMACEUT, B-2340 BEERSE, BELGIUM
[2] LIVERPOOL MATERN HOSP, DEPT CHILD HLTH, LIVERPOOL, ENGLAND
来源
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 1990年 / 65卷 / 04期
关键词
D O I
10.1136/adc.65.4_Spec_No.349
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The pharmacokinetics of alfentanil were studied during the first four days after birth in 22 ventilated preterm infants who were all receiving muscle relaxants. Five minutes after a single dose of 20 μg/kg alfentanil median serum concentration was 66 ng/ml (range: 20-606). The median clearance ws 0·87 ml/kg/min (range: 0·4-9·62) and median elimination half life 321 mins (64-1251). There were wide differences in the manner in which individual infants handled the drug and transient depression of blood pressure and heart rate was observed. These data were used to calculate an infusion dosage. In four infants 20 μg/kg alfentanil given by infusion over 30 minutes followed by 5 μg/kg/hour produced steady state median alfentanil concentrations of 54·5 ng/ml (range: 7-73 ng/ml) with no evidence of drug accumulation.
引用
收藏
页码:349 / 351
页数:3
相关论文
共 50 条
  • [11] POPULATION PHARMACOKINETICS OF PHENOBARBITAL IN PRETERM INFANTS
    DONN, SM
    GRASELA, TH
    CLINICAL RESEARCH, 1983, 31 (04): : A789 - A789
  • [12] INTRAVENOUS GENTAMICIN PHARMACOKINETICS IN PRETERM INFANTS
    THANGAVEL, M
    SELIGMAN, S
    MOEL, D
    RUDOLPH, N
    CLINICAL RESEARCH, 1980, 28 (01): : A91 - A91
  • [13] Pharmacokinetics and tolerance of zidovudine in preterm infants
    Capparelli, EV
    Mirochnick, M
    Dankner, WM
    Blanchard, S
    Mofenson, L
    McSherry, GD
    Gay, H
    Ciupak, G
    Smith, B
    Connor, JD
    JOURNAL OF PEDIATRICS, 2003, 142 (01) : 47 - 52
  • [14] Pharmacokinetics and renal function in preterm infants
    vandenAnker, JN
    ACTA PAEDIATRICA, 1996, 85 (12) : 1393 - 1399
  • [15] Pharmacokinetics and metabolism of oral midazolam in preterm infants
    de Wildt, SN
    Kearns, GL
    Hop, WCJ
    Murry, DJ
    Abdel-Rahman, SM
    van den Anker, JN
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 390 - 392
  • [16] Population pharmacokinetics of fentanyl in very preterm infants
    Bardol, Maddlie
    Fellman, Vineta
    Norman, Elisabeth
    Standing, Joseph
    PEDIATRIC RESEARCH, 2021, 90 (SUPPL 1) : 35 - 36
  • [17] PHARMACOKINETICS OF ORAL AND INTRAVENOUS INDOMETHACIN IN PRETERM INFANTS
    BHAT, R
    VIDYASAGAR, D
    FISHER, E
    HASTREITER, A
    RAMIREZ, JL
    BURNS, L
    EVANS, M
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1980, 1 (2-3): : 101 - 110
  • [18] Pharmacokinetics and metabolism of intravenous midazolam in preterm infants
    de Wildt, SN
    Kearns, GL
    Hop, WCJ
    Murry, DJ
    Abdel-Rahman, SM
    van den Anker, JN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (06) : 525 - 531
  • [19] Rifampin Pharmacokinetics and Safety in Preterm and Term Infants
    Smith, P. Brian
    Cotten, C. Michael
    Hudak, Mark L.
    Sullivan, Janice E.
    Poindexter, Brenda B.
    Cohen-Wolkowiez, Michael
    Boakye-Agyeman, Felix
    Lewandowski, Andrew
    Anand, Ravinder
    Benjamin, Daniel K., Jr.
    Laughon, Matthew M.
    Furda, Gary
    Benjamin, Danny
    Capparelli, Edmund
    Kearns, Gregory L.
    Paul, Ian M.
    Hornik, Christoph
    Wade, Kelly
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (06)
  • [20] EFFECTS OF INDOMETHACIN ON DIGOXIN PHARMACOKINETICS IN PRETERM INFANTS
    KOREN, G
    ZARFIN, Y
    PERLMAN, M
    MACLEOD, SM
    PEDIATRIC PHARMACOLOGY, 1984, 4 (01): : 25 - 30